Clinical Trials Detail

Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemo

A Randomized Phase III Post-Operative Trial of Platinum Based Chemo vs. Observation in Patients with Residual Triple- Basal-Like Breast Ca post Neoadj. Chemo

Objective
CategoryInformation
Study #: EA1131
Anatomic Site:

Breast

Histology: Breast Cancer
Mutation: Mutation: Estrogen Receptor Negative, HER2/Neu Negative, and Progesterone Receptor Negative (Triple Negative)
Stage: Stage IIA-IIIC
Treatment Phase: Must have histologically confirmed triple negative invasive breast cancer, clinical stage II-III at diagnosis. Patients must have completed neoadjuvant regimen and completed definitive resection of primary tumor.
Location:
Study Link: https://clinicaltrials.gov/ct2/show/NCT02445391?term=EA1131&rank=1

Clinical Trial Categories

  • Breast